Previous 10 | Next 10 |
CAESAREA, Israel, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea and uses a digital healthcare platform to facilitate the continuum of care for effe...
Acasti Pharma (NASDAQ: ACST ) initiated with Buy rating at B. Riley FBR. More news on: Acasti Pharma Inc., Blueprint Medicines Corporation, Dova Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Itamar Medical (NASDAQ: ITMR ): Q2 GAAP EPADS of -$0.18. More news on: Itamar Medical Ltd., Earnings news and commentary, , Read more ...
- Total Second Quarter Revenues Increase 21% to $7.4 Million - - WatchPAT TM Revenues Increase 16% in the Second Quarter to $6.5 Million - - Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT - CAESAREA, Israel, A...
CAESAREA, Israel, July 31, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, announced today that it will report its unaud...
TEL AVIV, Israel , June 26, 2019 /PRNewswire/ -- Itamar Medical's (NASDAQ: ITMR) (TASE: ITMR) revolutionary technology enables cardiologists to make better decisions and results in 30% assumed revenue growth by the end of 2019; Itamar Medical has a $6.8B addressable ma...
New system expands WatchPAT access to additional sleep centers by reducing infrastructure needs and eliminating capital requirements; also reduces infection risk for in-patient sleep apnea testing CAESAREA, Israel, June 06, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasda...
Collaboration designed to integrate sleep apnea management into cardiology care pathways CAESAREA, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea wi...
Collaboration designed to integrate sleep apnea management into cardiology care pathways CAESAREA, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea wi...
Itamar Medical (NASDAQ: ITMR ): Q1 GAAP EPS of $0.00. More news on: Itamar Medical Ltd., Earnings news and commentary, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
- Revenues Increase d 23 % Year-over-Year to $ 13.6 Million - - U.S. WatchPAT™ Revenues Increase d 27 % Year-over-Year t o $ 11.3 ...
Shares of Itamar Medical (NASDAQ: ITMR) were skyrocketing 44.5% as of 10:48 a.m. EDT on Monday. The huge gain came after Zoll Medical, which is owned by Japanese materials science company Asahi Kasei (OTC: AHKSY) , announced plans to acquire Itamar for $538 million. The ...